| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $675.4M | +15.8% |
| Cost of Revenue | $647.8M | +16.0% |
| R&D Expense | $37.5M | +66.6% |
| SG&A Expense | $221.5M | +318.6% |
| Operating Income | -$253.3M | -248.8% |
| Interest Expense | $16.9M | +47.0% |
| Pre-tax Income | -$281.7M | -276.5% |
| Income Tax | -$76K | -104.6% |
| Net Income | -$281.8M | -285.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.1M | +1223.4% |
| Accounts Receivable | $65.9M | +54.5% |
| Current Assets | $150.8M | — |
| Total Assets | $204.0M | -36.8% |
| Current Liabilities | $267.4M | — |
| Long-term Debt | $69.5M | +36.2% |
| Total Liabilities | $358.5M | +3081.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.0M | -118.9% |
| Investing Cash Flow | -$76.1M | -1802.1% |
| Financing Cash Flow | $206.6M | +201.8% |
| Stockholders' Equity |
| -$303.2M |
| -3068.0% |